Manufacturer record
Mercury Laboratories Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Mercury Laboratories Limited (Gujarat) were declared Not of Standard Quality between March 2020 and October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 24110214, Amlodipine Tablets IP 5mg (exp Jul 2027). DTL, Jaipur (state lab) found it not of standard quality: The sample does not conform to the IP with respect to Assay. Listed in the October 2025 alert.
Records by type
11 records linked to Mercury Laboratories Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amlodipine Tablets IP 5mg | Batch 24110214Mfg Aug 2024 · Exp Jul 2027 | The sample does not conform to the IP with respect to Assay.Assay | DTL, JaipurState lab | Oct 2025 |
| Levocetirizine Dihydrochloride and Montelukast Sodium Tablets IP | Batch 23112701Mfg Mar 2023 · Exp Feb 2025 | Dissolution of MontelukastDissolution | RDTL GuwahatiCDSCO lab | Jun 2024 |
| Levocetirizine Dihydrochloride and Montelukast Sodium Tablets IP | Batch 23112703Mfg Mar 2023 · Exp Feb 2025 | Dissolution of MontelukastDissolution | RDTL GuwahatiState lab | Feb 2024 |
| Levocetirizine Dihydrochloride and Montelukast Sodium Tablets IP | Batch 22112701Mfg Jan 2022 · Exp Dec 2023 | DissolutionDissolution | CDL KolkataCDSCO lab | Oct 2022 |
| Levocetirizine Dihydrochloride and Montelukast Sodium Tablets IP | Batch 21112704Mfg May 2021 · Exp Apr 2023 | Dissolution of MontelukastDissolution | RDTL GuwahatiCDSCO lab | Aug 2022 |
| Levocetirizine Dihydrochloride and Montelukast Sodium Tablets IP) | Batch 21112704Mfg May 2021 · Exp Apr 2023 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2022 |
| Levocetirizine Dihydrochloride and Montelukast Sodium Tablets IP) | Batch 22112701Mfg Jan 2022 · Exp Dec 2023 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2022 |
| Levocetirizine Dihydrochloride & Montelukast Sodium Tablets IP | Batch 21112704Mfg May 2021 · Exp Apr 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2022 |
| Salbutamol Tablets IP 4mg. | Batch 21112002Mfg May 2021 · Exp Apr 2024 | DisintegrationDisintegration | RDTL GuwahatiState lab | Jun 2022 |
| Levocetirizine Dihydrochloride and Montelukast Sodium Tablets IP | Batch 21112701Mfg Jan 2021 · Exp Dec 2022 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Apr 2022 |
| Methylergometrine Maleate Tablets IP | Batch 19113201Mfg Jun 2019 · Exp May 2021 | AssayAssay | RDTL ChandigarhCDSCO lab | Mar 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.